[Zanubrutinib - Relapsed or refractory follicular lymphoma]

Fiona Grant-Monlouis-Felicite; Nadia Diop

doi:10.1016/j.bulcan.2024.02.009

[Zanubrutinib - Relapsed or refractory follicular lymphoma]

Bull Cancer. 2024 Apr 5:S0007-4551(24)00115-2. doi: 10.1016/j.bulcan.2024.02.009. Online ahead of print.

[Article in French]

Authors

Fiona Grant-Monlouis-Felicite¹, Nadia Diop²

Affiliations

¹ Établissement français du Sang, IUCT Oncopole, 1, avenue Irène-Joliot-Curie, 31000 Toulouse, France. Electronic address: grantmontlouisfelicite.fiona@iuct-oncopole.fr.
² Service de thérapies cellulaires et d'hématologie clinique, CHU Estaing, 1, place Lucie-et-Raymond-Aubrac, Clermont- Ferrand, France.

PMID: 38582740
DOI: 10.1016/j.bulcan.2024.02.009

No abstract available

Keywords: BTK inhibitors; Follicular lymphoma; Inhibiteurs de BTK; Lymphome folliculaire; Lymphoproliferative disease; Syndromes lymphoprolifératifs; Zanubrutinib.

Publication types

Letter